Clinical Trials Browser

Phase 1 × Bryostatins × Dermatologic × Clear all

NCT00112476 2013-05-03

Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors

Phase 1 Completed

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma